Palbociclib (PD0332991) Isethionate
商品编号:
TS0325
备注:
如需更大包装,请联系销售人员,大包装有极大的折扣优惠!
详细介绍
l 基本信息 |
产品名称 | 羟乙基磺酸帕博西丽(Palbociclib Isethionate) |
一般描述 | Palbociclib Isethionate is the isethionate salt form of palbociclib, an orally available CDK inhibitor with potential antineoplastic activity. |
别 称 | 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one;2-hydroxyethanesulfonic acid; PD0332991 Isethionate |
纯 度 | ≥98.0%(HPLC) | CAS NO. | 827022-33-3 |
分子式 | C24H29N7O2·C2H6O4S | 分子量 | 573.66 |
适用范围 | 生物试剂,适用于细胞培养等 |
l 理化信息 |
外 观 | 固体 |
溶解性(25℃) | DMSO | Insoluble |
乙醇 | Insoluble |
水 | ≥5mg/mL(warmed) |
l 生物学信息 |
生物活性/药理作用 | Palbociclib Isethionate is the isethionate salt form of palbociclib, an orally available CDK inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin-dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine/threonine kinases that are upregulated in many tumor cell types and play a key role in the regulation of cell cycle progression. Palbociclib Isethionate is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM in cell-free assays. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. |
l 存储 |
存储温度 | -20℃ |
l 注意事项及免责声明 |
本产品仅用于实验研究,不得作为药物使用,不得用于家用或其它用途。 |
l 参考文献 |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |